论文部分内容阅读
作者对５０例原发胃肠道非霍奇金淋巴瘤（ＧＩ－ＮＨＬ）的预后因素进行了分析。结果显示：临床分期Ⅰ、Ⅱ期病人预后明显优于Ⅳ期，５年存活率分别为６８．９％，８．３％（Ｐ＜０．０１）。在Ⅳ期病人中手术切除肿块者优于未切除者（Ｐ＜０．０５）。病理分类低度恶性者５年存活率略高于中／高度恶性者，分别为７５％，４０．８％（ｘ２＝１．７３５Ｐ＜０．２）。性别、年龄与预后无关。提示早期诊断、积极手术治疗是原发ＧＩ－ＮＨＬ长期生存的关键所在。
The authors analyzed the prognostic factors of 50 cases of primary gastrointestinal non-Hodgkin’s lymphoma (GI-NHL). The results showed that the prognosis of stage I and II patients was significantly better than that of stage IV. The 5-year survival rates were 68.9% and 8.3%, respectively (P<0.01). Surgical removal of tumors in stage IV patients was superior to those without resection (P < 0.05). The 5-year survival rate of pathologically classified low-grade malignancy was slightly higher than that of moderate-to-high-grade malignancy, which were 75% and 40.8%, respectively (x2=1.735P<0.2). Gender, age, and prognosis have nothing to do. It is suggested that early diagnosis and active surgical treatment are the key to the long-term survival of primary GI-NHL.